Abstract
Over the last 20 years, supervised injectable and inhalable heroin prescribing has been developed, tested and in some cases introduced as a second line treatment for limited groups of entrenched heroin users in a number of European countries and Canada. Based on documentary analyses and eleven key informant interviews, this paper investigates the growth of 'expertise' and the sharing of knowledge between scientific stakeholders from different countries involved in researching and developing this area of treatment. Drawing on Stone's concept of the 'knowledge network' (Stone, 2013) and Gieryn's theory of 'boundary-work' (Gieryn, 1983), the analysis demonstrates the collective power of this group of scientists in producing a particular form of knowledge and expertise which has accrued and been exchanged over time. It also illustrates the ways in which this type of science has gained credibility and authority and become legitimised, reinforced and reproduced by those who employ it in both scientific and political debates. Boundaries were constructed by the knowledge network between different types of professions/disciplines, different forms of science and between the production of science and its consumption by non-scientists. The...Continue Reading
References
Jul 4, 1998·BMJ : British Medical Journal·T V PernegerA Mino
Nov 14, 2001·Lancet·J RehmA Uchtenhagen
Aug 9, 2003·BMJ : British Medical Journal·Wim van den BrinkJan M van Ree
Aug 2, 2005·Journal of Health Services Research & Policy·Trevor A Sheldon
Aug 22, 2006·Journal of Substance Abuse Treatment·Joan Carles MarchUNKNOWN PEPSA team
Jul 3, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Christian HaasenDieter Naber
May 18, 1990·Science·S Jasanoff
Jan 23, 2009·Harm Reduction Journal·Candice C GartryMartin T Schechter
Mar 27, 2009·Drug and Alcohol Review·Nuria RomoUNKNOWN PEPSA Team
Aug 21, 2009·The New England Journal of Medicine·Eugenia Oviedo-JoekesMartin T Schechter
Dec 18, 2009·Clinical Trials : Journal of the Society for Clinical Trials·Joan Trujols, Ioseba Iraurgi
Apr 14, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Peter BlankenJan M van Ree
Jun 1, 2010·Lancet·John StrangLuciana Forzisi
Apr 19, 2013·Harm Reduction Journal·Susan Boyd, Naomi Patients Association
Feb 12, 2014·European Addiction Research·Riaz KhanAmbros Uchtenhagen
Mar 4, 2014·The International Journal on Drug Policy·Karen Duke, Betsy Thom
Mar 22, 2014·International Journal of Qualitative Studies on Health and Well-being·Ehsan Jozaghi
Apr 4, 2015·European Addiction Research·Isabelle DemaretMarc Ansseau